Director of Cardiac Cath Lab
Cardiology
Dr. Michael W. Cleman, MD
|
|
Give Review
Michael Cleman practices Cardiology. He researched medicine at Yale University School of Medicine. Yale University School of Medicine is a top medical college. Yale University School of Medicine is ranked 7 in research and 57 in primary care medicine He received 5 awards: "Top Doctors: New York Metro Area", "CMS Meaningful Use Stage 1 Certification", "New York Magazine: Top Doctors", "Top MD" and "Fellow (FACC)". Dr. Michael W. Cleman is also a published MD. He has 72 paper published. The most recent paper is: Modulation of circulating cellular adhesion molecules in postmenopausal women with coronary artery disease. He is registered with Medicare.
Publications
- Intravascular Ultrasound in Lower Extremity Peripheral Vascular Interventions: Variation in Utilization and Impact on In-Hospital Outcomes From the Nationwide Inpatien...
- Impact of glycoprotein IIb/IIIa inhibitors use on outcomes after lower extremity endovascular interventions from nationwide inpatient sample (2006-2011).
- Transcatheter pulmonary Valve implantation: A cross-sectional US experience.
- Mechanical Circulatory Support Devices and Transcatheter Aortic Valve Implantation (from the National Inpatient Sample).
- Impact of Hospital Volume on Outcomes of Endovascular Stenting for Adult Aortic Coarctation.
- A balloon-expandable sheath facilitates transfemoral TAVR in patients with peripheral vascular Disease and tortuosity.
- Usefulness of Colchicine to Reduce Perioperative Myocardial Damage in Patients Who Underwent On-Pump Coronary Artery Bypass Grafting.
- Comparison of Outcomes of Balloon Aortic Valvuloplasty Plus Percutaneous Coronary Intervention Versus Percutaneous Aortic Balloon Valvuloplasty Alone During the Same H...
- Red blood cell and platelet microparticles in Myocardial infarction patients treated with primary angioplasty.
- Effect of Angiotensin Converting Enzyme Inhibitors on Soluble Tumor-Necrosis-Factor-Related Apoptosis-Inducing Ligand Levels - Association With Neointimal Hyperplasia ...
- Anomalous left Coronary artery in hypertrophic cardiomyopathy.
- Association of virtual histology characteristics of the culprit plaque with post-fibrinolysis flow restoration in ST-elevation Myocardial infarction.
- Anti-Inflammatory Treatment With Colchicine in Stable Chronic Heart Failure: A Prospective, Randomized Study.
- Colchicine for prevention of Atrial fibrillation recurrence after pulmonary vein isolation: Mid-term efficacy and effect on quality of life.
- Association of asymmetric dimethylarginine levels with treadmill-stress-test-derived prognosticators.
- Colchicine and the Heart: pushing the envelope.
- Copeptin as a biomarker in cardiac Disease.
- Association of soluble tumour necrosis factor-related apoptosis-inducing ligand levels with Coronary plaque burden and composition.
- Sheathless transulnar versus standard femoral arterial access for percutaneous Coronary intervention on bifurcation lesions.
- Comparison of coronary artery specific leukocyte-platelet conjugate formation in unstable versus stable Angina pectoris.
- Electromechanical mapping for detecting myocardial viability and ischemia in patients with severe ischemic Cardiomyopathy.
- Multicenter evaluation of noninvasive cardiac output measurement by bioreactance technique.
- Percutaneous right ventricular support during catheter ablation of intra-Atrial reentrant tachycardia in an adult with a mustard baffle--a novel use of the Impella dev...
- Percutaneous transluminal coronary angioplasty in unstable and stable Angina pectoris: a comparison of immediate success and complications.
- Predictors of coronary Dissection following percutaneous transluminal coronary balloon angioplasty.
- Efficacy of Coronary stenting versus balloon angioplasty in small Coronary arteries. Stent Restenosis Study (STRESS) Investigators.
- Clinical experience with the Palmaz-Schatz Coronary stent.
- Metabolic and functional effects of perfluorocarbon distal perfusion during Coronary angioplasty.
- Myocardial dysfunction during percutaneous transluminal Coronary angioplasty.
- Percutaneous transluminal coronary angioplasty of the "culprit lesion" for management of unstable Angina pectoris in patients with multivessel coronary artery disease.
- Prevention of ischemia during percutaneous transluminal Coronary angioplasty by transcatheter infusion of oxygenated Fluosol DA 20%.
- Regional myocardial dysfunction during Coronary angioplasty: evaluation by two-dimensional echocardiography and 12 lead electrocardiography.
- Oxygenated fluosol DA-20% distal infusion during Coronary angioplasty protects myocardial function.
- Silent ischemia during Coronary occlusion produced by balloon inflation: relation to regional myocardial dysfunction.
- Preservation of left ventricular ejection fraction during percutaneous transluminal Coronary angioplasty by distal transcatheter Coronary perfusion of oxygenated Fluos...
- Left ventricular systolic performance during upright bicycle exercise in patients with essential Hypertension.
- Length of hospital stay and complications after percutaneous transluminal Coronary angioplasty. Clinical and procedural predictors. Heparin Registry Investigators.
- In-hospital and one-year economic outcomes after Coronary stenting or balloon angioplasty. Results from a randomized clinical trial. Stent Restenosis Study Investigators.
- Myocardial blood flow as a determinant factor in the electrical stability of the myocardium.
- Coronary angioplasty with gradual versus rapid balloon inflation: initial results and complications.
- Clinical and angiographic determinants of initial percutaneous transluminal Coronary angioplasty success.
- Health after Coronary stenting or balloon angioplasty: results from the Stent Restenosis Study.
- IntraCoronary Doppler assessment of moderate Coronary artery disease: comparison with 201Tl imaging and Coronary angiography. FACTS Study Group.
- Economic assessment of platelet glycoprotein IIb/IIIa inhibition for prevention of ischemic complications of high-risk Coronary angioplasty. EPIC Investigators.
- Myocardial risk area defined by technetium-99m sestamibi imaging during percutaneous transluminal Coronary angioplasty: comparison with Coronary angiography.
- Fate of lesion-related side branches after Coronary artery stenting.
- Physiologic assessment of ostial left circumflex Coronary artery disease using a Doppler guidewire before and after rotational atherectomy facilitated angioplasty.
- Insulin degradation in serum of a patient with apparent insulin resistance.
- Unsuspected left ventricular pseudoAneurysm.
- Myocardial protection during percutaneous transluminal Coronary angioplasty.
- Update on percutaneous transluminal Coronary angioplasty.
- Percutaneous transluminal coronary angioplasty during Acute myocardial infarction.
- Dynamics of early and late left ventricular filling determined by Doppler two-dimensional echocardiography during percutaneous transluminal Coronary angioplasty.
- Coronary vasospasm culminating in thrombosis and infarction following "successful" Coronary angioplasty.
- Pulmonary and pleural complications of cardiac Disease.
- Predictors of success in percutaneous transluminal Coronary angioplasty of chronic total occlusions.
- Inadvertent "atherectomy" during ostial right Coronary artery angioplasty.
- Reduction of myocardial ischemia during percutaneous transluminal Coronary angioplasty with oxygenated Fluosol.
- Validation of continuous radionuclide left ventricular functioning monitoring in detecting silent Myocardial ischemia during balloon angioplasty of the left anterior d...
- Clinical experience with the Palmaz-Schatz Coronary stent. Initial results of a multicenter study.
- Effect of intracoronary stenting on intimal Dissection after balloon angioplasty: results of quantitative and qualitative coronary analysis.
- The right ventricle in disorders causing Pulmonary venous hypertension.
- Restenosis after placement of Palmaz-Schatz stents in native Coronary arteries. Initial results of a multicenter experience.
- Fractional flow reserve compared with intravascular ultrasound guidance for optimizing stent deployment.
- Serum complement activation in congestive Heart failure.
- Final results of the Can Routine Ultrasound Influence Stent Expansion (CRUISE) study.
- Modulation of circulating cellular adhesion molecules in postmenopausal women with Coronary artery disease.
- Acute and long-term outcome after Palmaz-Schatz stenting: analysis from the New Approaches to Coronary Intervention (NACI) registry.
- High-speed rotational atherectomy of human coronary stenoses: Acute and one-year outcomes from the New Approaches to Coronary Intervention (NACI) registry.
- Long-term angiographic and clinical outcome after implantation of a balloon-expandable stent in the native Coronary circulation. Palmaz-Schatz Stent Study Group.
- Immediate results and late outcomes after stent implantation in saphenous vein graft lesions: the multicenter U.S. Palmaz-Schatz stent experience. The Palmaz-Schatz St...
Schools
Johns Hopkins University School Of Medicine
Shands Tchg Hospital
Yale Med School Yale New Haven Hospital
Procedures Preformed
- Ablation for Treatment of Cardiac Arrhythmias
- Automatic Implantable Cardioverter Defibrillator (ICD) Implantation
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- View All
Conditions Treated
- Aneurysm and Dissection of Heart
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Dissection
- View All
Doctors Specialties
- Cardiology
- Interventional Cardiology
Accepted Insurances
Awards
- Top Doctors: New York Metro Area
- CMS Meaningful Use Stage 1 Certification
- New York Magazine: Top Doctors
- Top MD
- Fellow (FACC)
Education
-
Yale University School of Medicine -
University of Florida -
Johns Hopkins University School of Medicine
Hospital
-
Greenwich Hospital -
Yale-New Haven Hospital
Drug Facts
| NPI NUMBER | 1023006269 | |
| NPPES Provider LastName | CLEMAN | |
| NPPES Provider FirstName | MICHAEL | |
| NPPES Provider ZIPCode | 064053607 | |
| NPPES Provider State | CT | |
| Specialty Description | Cardiology | |
| Total Claim Count | 2352.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1023006269 |
| Last Name Of The Provider | CLEMAN |
| First Name Of The Provider | MICHAEL |
| View All |
Similar Doctors
|
Dr. Ramak A. Attaran, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Steven E. Pfau, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jeptha P. Curtis, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Dan Jane-Wit, MD |
|
|
Dr. Michael S. Remetz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Raymond R. Russell, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert McNamara, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kerry S. Russell, MD |
|
|
Dr. John K. Forrest, MD |